Last Close
Apr 09  •  04:00PM ET
7.92
Dollar change
-0.08
Percentage change
-1.00
%
Index
-
P/E
-
EPS (ttm)
-0.78
Insider Own
2.80%
Shs Outstand
682.00M
Perf Week
1.93%
Market Cap
5.40B
Forward P/E
9.37
EPS next Y
0.85
Insider Trans
4.44%
Shs Float
662.99M
Perf Month
-2.82%
Enterprise Value
9.17B
PEG
27.57
EPS next Q
0.16
Inst Own
101.09%
Perf Quarter
-34.44%
Income
-530.20M
P/S
0.82
EPS this Y
-12.68%
Inst Trans
1.96%
Perf Half Y
-41.20%
Sales
6.55B
P/B
0.97
EPS next Y
7.53%
ROA
-4.44%
Perf YTD
-30.89%
Book/sh
8.16
P/C
14.78
EPS next 5Y
0.34%
ROE
-9.20%
52W High
16.17 -51.02%
Perf Year
-50.16%
Cash/sh
0.54
P/FCF
10.91
EPS past 3/5Y
- -
ROIC
-5.50%
52W Low
7.26 9.02%
Perf 3Y
-61.74%
Dividend Est.
-
EV/EBITDA
9.29
Sales past 3/5Y
-4.46% 0.49%
Gross Margin
31.50%
Volatility
4.84% 4.71%
Perf 5Y
-75.04%
Dividend TTM
-
EV/Sales
1.40
EPS Y/Y TTM
-174.31%
Oper. Margin
8.80%
ATR (14)
0.38
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.18
Sales Y/Y TTM
-3.41%
Profit Margin
-8.09%
RSI (14)
43.24
Dividend Gr. 3/5Y
- -
Current Ratio
1.78
EPS Q/Q
-89.48%
SMA20
2.09%
Beta
0.97
Payout
-
Debt/Eq
0.74
Sales Q/Q
-1.36%
SMA50
-10.53%
Rel Volume
0.77
Prev Close
8.00
Employees
13500
LT Debt/Eq
0.73
SMA200
-31.96%
Avg Volume
11.43M
Price
7.92
IPO
May 17, 2019
Option/Short
Yes / Yes
Trades
Volume
8,791,473
Change
-1.00%
Date Action Analyst Rating Change Price Target Change
Mar-06-26Downgrade Barclays Equal Weight → Underweight $8.50
Jan-05-26Downgrade Evercore ISI Outperform → In-line $12
Dec-17-25Downgrade Jefferies Hold → Underperform $9
Dec-15-25Downgrade BofA Securities Buy → Neutral $13
Nov-04-25Downgrade Raymond James Outperform → Mkt Perform
Oct-30-25Downgrade JP Morgan Overweight → Neutral $12
Oct-30-25Downgrade Barclays Overweight → Equal Weight $12
Aug-01-25Downgrade Jefferies Buy → Hold
Apr-29-25Downgrade Goldman Buy → Neutral $14
Apr-28-25Downgrade TD Cowen Buy → Hold $15.50
Apr-03-26 08:05AM
Apr-01-26 08:00AM
Mar-06-26 09:31AM
Mar-05-26 04:57AM
Mar-04-26 12:41PM
05:19AM Loading…
Mar-02-26 05:19AM
Feb-27-26 02:45PM
Feb-26-26 09:26AM
Feb-18-26 04:36AM
04:30AM
12:36AM
Feb-17-26 01:43AM
Feb-14-26 01:25AM
Feb-12-26 10:41AM
12:33AM
02:23PM Loading…
Feb-11-26 02:23PM
02:01PM
01:50PM
01:42PM
12:32PM
09:30AM
07:15AM
06:17AM
06:05AM
Feb-09-26 10:08PM
Feb-06-26 09:40AM
Feb-05-26 11:40AM
Feb-04-26 07:40AM
Feb-01-26 09:21AM
Jan-12-26 08:05AM
08:29AM Loading…
Jan-08-26 08:29AM
Jan-05-26 08:05AM
Jan-02-26 09:44AM
Jan-01-26 11:04PM
Dec-26-25 09:00AM
Dec-25-25 11:50PM
Dec-24-25 04:32AM
Dec-23-25 09:00AM
Dec-22-25 03:15AM
Dec-18-25 10:31PM
08:05AM
Dec-12-25 09:45AM
Dec-11-25 07:52AM
Dec-10-25 01:06PM
Dec-09-25 08:42AM
Dec-08-25 06:13AM
Dec-04-25 04:15PM
Nov-25-25 08:05AM
Nov-19-25 08:05AM
Nov-11-25 04:30AM
Nov-10-25 08:30AM
Nov-05-25 12:36AM
Nov-03-25 02:43AM
Oct-31-25 05:00PM
03:20PM
Oct-30-25 02:02PM
11:26AM
08:05AM
01:33AM
Oct-29-25 03:46PM
09:30AM
07:15AM
06:16AM
06:05AM
Oct-27-25 11:05PM
11:44AM
Oct-24-25 08:07AM
Oct-23-25 08:05AM
Oct-22-25 10:00AM
Oct-21-25 01:41PM
12:04AM
Oct-17-25 12:23PM
Oct-15-25 08:05AM
Oct-13-25 04:05PM
Oct-03-25 01:05PM
08:05AM
Oct-02-25 11:35PM
Oct-01-25 05:34PM
08:05AM
Sep-19-25 09:05AM
Sep-03-25 02:45PM
Aug-27-25 04:32PM
Aug-26-25 12:37AM
Aug-19-25 08:00AM
Aug-13-25 05:51PM
12:12AM
12:05AM
Aug-11-25 04:15PM
12:31PM
12:00PM
11:24AM
10:30AM
09:48AM
09:33AM
08:33AM
07:00AM
Aug-10-25 06:00PM
Aug-04-25 12:06PM
Aug-02-25 10:22AM
03:05AM
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEHRA SANJEEV KDirectorMar 10 '26Buy8.01125,0001,001,250475,000Mar 11 05:10 PM
LUCIER GREGORY TDirectorFeb 19 '26Buy9.1650,000458,00050,000Feb 23 08:53 PM
SUMME GREGORY LDirectorFeb 12 '26Buy9.40100,000940,000400,000Feb 12 05:24 PM
MEHRA SANJEEV KDirectorDec 05 '25Buy11.09350,0003,881,500350,000Dec 09 05:11 PM
Ligner EmmanuelPresident and CEONov 17 '25Buy11.3587,500993,125283,424Nov 17 05:45 PM
Todd EdwardsofficerNov 06 '25Proposed Sale25.1629,131732,926Nov 06 04:26 PM
SUMME GREGORY LDirectorOct 30 '25Buy11.25100,0001,125,000300,000Oct 31 09:46 AM
SUMME GREGORY LDirectorAug 21 '25Buy12.56100,0001,256,000200,000Aug 22 04:15 PM
Eck Steven WSVP & Chief Accounting OfficerAug 05 '25Sale11.393,47639,59255,068Aug 06 04:32 PM
Eck Steven WOfficerAug 05 '25Proposed Sale11.393,47639,592Aug 05 10:58 AM
SUMME GREGORY LDirectorMay 23 '25Buy12.5030,000375,000100,000May 27 04:58 PM
SUMME GREGORY LDirectorMay 22 '25Buy12.6520,000253,00070,000May 22 05:37 PM
SUMME GREGORY LDirectorMay 07 '25Buy12.0025,000300,00050,000May 09 04:51 PM
Massaro Joseph RDirectorApr 29 '25Buy12.308,10099,63035,038Apr 29 05:58 PM
SUMME GREGORY LDirectorApr 28 '25Buy12.5025,000312,50025,000Apr 29 05:58 PM
Kang LanDirectorApr 28 '25Buy12.575,00062,85035,215Apr 29 05:58 PM
Peacock Jonathan MDirectorApr 28 '25Buy12.818,091103,646202,715Apr 29 05:58 PM